There is no published data on its use in children with RCC.
2
RCC-Ma expression is relatively specific for primary clear cell renal cell carcinoma.
3
Conclusion: Dendritic cell vaccination can safely induce an immunological response against RCC.
4
These images were taken yesterday and have been relayed to RCC Australia.
5
Hence, novel and more effective therapeutic options for advanced RCC are needed.
1
We enrolled 129 CCRCC patients containing at least two different nuclear grades.
2
Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging.
3
In conclusion, TYROBP may have potential for diagnosis and treatment of ccRCC.
4
They also explain why a mouse model of ccRCC has been lacking.
5
Moreover, the RET nuclear expression was an independent predictor of ccRCC postoperative metastasis.
1
Many of the nonpapillaryrenalcellcarcinomas with papillary architecture have been recognized only recently.
Ús de clear cell renal cell carcinoma en anglès
1
RCC-Ma expression is relatively specific for primary clearcellrenalcellcarcinoma.
2
Histologic examination revealed a metastatic clearcellrenalcellcarcinoma.
3
Current therapies for metastatic clearcellrenalcellcarcinoma (ccRCC) show limited efficacy.
4
She underwent radical nephrectomy and biopsy revealed clearcellrenalcellcarcinoma, Fuhrman grade 4.
5
Aim: A nine-year retrospective analysis of patients with clearcellrenalcellcarcinoma undergoing surgical treatment of pulmonary metastases.
6
However, its precise role in clearcellrenalcellcarcinoma (hereafter termed RCC) remains to be delineated.
7
Nuclear grade is one of the most important prognostic factors in clearcellrenalcellcarcinoma (CCRCC).
8
Patient summary: Cancer-specific RNA alternative splicing may portend a poor prognosis in patients with advanced clearcellrenalcellcarcinoma.
9
Materials and methods: We included 264 individuals who were diagnosed with non-metastatic clearcellrenalcellcarcinoma in the present study.
10
Importance: There are well-documented racial disparities in outcomes for African American patients with clearcellrenalcellcarcinoma (ccRCC).
11
Purpose: Tumor heterogeneity may represent a barrier to preoperative genomic characterization by needle biopsy in clearcellrenalcellcarcinoma (ccRCC).
12
A 71-year-old woman underwent right nephrectomy for the treatment of clearcellrenalcellcarcinoma at the age of 53.
13
Analysis of RNA-sequencing data revealed that bladder cancer had significantly lower levels of PSMA expression than both prostate cancer and clearcellrenalcellcarcinoma.
14
The aim of the study was to investigate the prognostic roles of intratumoral changes in surgical treated localized clearcellrenalcellcarcinoma (ccRCC).
15
We attempted to determine whether cytoplasmic fat in clearcellrenalcellcarcinoma (RCC) can be identified by chemical shift gradient-echo magnetic resonance imaging (CSI).
16
Materials and methods: We identified 1,864 patients who underwent partial or radical nephrectomy for nonmetastatic clearcellrenalcellcarcinoma between 1970 and 2000.